The non-invasive imaging laboratories in the Knight Cardiovascular Institute are at the leading edge of research in cardiovascular medicine. Highlights of our program include:
- Researchers at the Knight Cardiovascular Institute developed myocardial contrast echocardiography (MCE)—a powerfully effective screening test for the early detection of coronary heart disease.
- Our investigators are pioneers in ultrasound-based molecular imaging techniques aimed at improving diagnosis and advancing cardiovascular therapeutics.
- Research programs exist within each of the major non-invasive imaging domains including echocardiography, cardiac computed tomography, cardiac magnetic resonance, and nuclear cardiology.
We study the molecular imaging of inflammation, ischemia, and angiogenesis with site-targeted ultrasound contrast agents, drug and gene delivery with ultrasound, and microvascular physiology at the capillary level. Our research holds the potential to improve patient outcomes by allowing diagnosis of disease at an early-stage, monitoring disease progression, and tailoring therapy to the molecular basis of disease.
Our institute offers a wide range of translational imaging facilities, including non-invasive imaging of non-human primate models, pre-clinical and clinical experimental imaging. Our facilities provide state-of-the-art imaging technology, but also guidance on imaging protocols and unique applications of the technologies.